ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Deals this week: Mundipharma, Ligand Pharmaceuticals
pharmaceutical-technology
November 25, 2018Kolon Life Sciences dosed the first patient in a Phase III trial for Invossa this month. It is hoping to be granted the US Food and Drug Administration’s (FDA) Disease Modifying Osteoarthritis Drug (DMOAD) label. -
Deals this week: Mundipharma, Ligand Pharmaceuticals
pharmaceutical-technology
November 25, 2018Kolon Life Sciences dosed the first patient in a Phase III trial for Invossa this month. It is hoping to be granted the US Food and Drug Administration’s (FDA) Disease Modifying Osteoarthritis Drug (DMOAD) label.
Pharma Sources Insight January 2025
